Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial.
Zhou Y, Wu F, Shi Z, Cao J, Tian J, Yao W, Wei L, Li F, Cai S, Shen Y, Wang Z, Zhang H, Chen Y, Fu Y, He Z, Chang C, Jiang Y, Chen S, Yang C, Yu S, Tian H, Cheng Q, Zhao Z, Ying Y, Zhou Y, Liu S, Deng Z, Huang P, Zhang Y, Luo X, Zhao H, Gui J, Lai W, Hu G, Liu C, Su L, Liu Z, Huang J, Zhao D, Zhong N, Ran P; China N-acetylcysteine in Mild-to-moderate COPD Study Group.
Zhou Y, et al.
Nat Commun. 2024 Sep 30;15(1):8468. doi: 10.1038/s41467-024-51079-1.
Nat Commun. 2024.
PMID: 39349461
Free PMC article.
Clinical Trial.